February 2022, In Australia, SW2™ is a Therapeutic Goods Administration (TGA) listed hospital-grade disinfectant effective against germs, bacteria, and COVID-19. The novel formulation has been registered by the Environmental Protection Agency under the name Sphinx.
Per the TGA listing, SW2™ prevents avoidable infection by forming a protective coating that makes surfaces hostile to germs. This means that 15 weeks after a single application it is still delivering up to a 98.5% reduction in germs, even with regular cleaning, compared to untreated surfaces that also undergo regular cleaning.
When lab tested in harsh conditions SW2™ lasts. Following simulated cleaning cycles equivalent to 90 days (a combination of dry and chemical abrasions totalling 1,620 contacts) on high touch surfaces such as door handles, SW2™ was still delivering a 99.9% reduction against bacteria and COVID-19.
While traditional disinfectants only provide momentary protection against germs, SW2™, exclusively distributed by Allied BioServices in Australia, ensures safe and hygienic spaces, which enable you to revert to pre-COVID cleaning protocols and reduce waste.
“Here in Australia, we achieved TGA registration in 2020, and SW2™ remains the only product on the market that sustains 105-day residual efficacy,” said Allied BioServices’ CEO Tim Smith.
“It’s great to see that the SW2™ formulation has achieved EPA registration in the USA.”
About Allied BioServices
Allied BioServices is an Australian company operating across Australia and New Zealand. It provides the world’s best infection control technologies and services to prevent avoidable infection and protect people’s health. Allied BioServices’ technologies and services are guaranteed to deliver proven, high-quality outcomes that are sustainable and eco-friendly. Our technologies and services create safer spaces.